List of Vendor Companies in Singapore - 20

Allozymes is a fast-growing biotechnology company that applies its proprietary ultra-high-throughput platform technology to rapidly develop novel enzymes and unlock the bioeconomy across sectors. Leveraging this ultra-high screening power, Allozymes aims to build the largest enzyme data library in the world to address the current and future needs of building robust biosolutions.

Auristone is an Asian-based epigenomic profiling company powered with data analytics capabilities and extensive epigenomic know-how. We use our comprehensive portfolio of Asian epigenomic database to power data-driven drug and biomarker discoveries. EPI-Call™ is our Flagship second generation Next Generation Sequencing (NGS) test. In addition to genomic information (DNA-seq), EPI-Call™ further provides epigenomic information around the tumour micro-environment and predicts patient response to immunotherapy. EPI-Call™ is the pragmatic choice to aid physicians in deciding the best treatment option for their patients. We are committed to supporting clinical and academic epigenomic research, and moving such research outcomes into the clinical setting. Driven by our aspiration to improve the quality of life for patients through better treatment, we are continuously seeking ways to bring our technologies to our clinical and academic partners. For more information on the company, drop us a line at enquiry@auristone.com or visit our website at www.auristone.com.

Biolidics – Bringing clarity to cancer Biolidics Ltd, formerly known as Clearbridge BioMedics, is a medical technology company focusing on the development of cell enrichment systems which, when combined with other analytical tests, have a wide range of applications for cancer diagnosis, prognosis, treatment selection and treatment monitoring. Biolidics has developed patented technology and solutions with the potential to serve as a platform technology for the diagnosis, prognosis, treatment selection and treatment monitoring of various types of cancers. The ClearCell® FX1 System by Biolidics is a fully automated CE-IVD medical device which relies on a novel patented technology to separate and enrich cancer cells from blood. This allows users of the system to perform liquid biopsies to test for the presence of cancer cells (specifically circulating tumour cells, or CTCs) in blood samples or perform further analysis on cancer cells, providing a simple and minimally invasive alternative to tissue biopsies, which involve the surgical removal of tissue from a patient's body. Our patented award-winning microfluidic technologies have many applications throughout the various stages of a patient's cancer journey, from cancer screening and staging to personalised treatment, and post-cancer monitoring. The ClearCell® FX1 System has been installed in academic and research institutes, hospitals and laboratories across the world, including Singapore, China, Hong Kong, Japan, the US and certain EU countries. Biolidics is a spin-off from the National University of Singapore (NUS) / SMART MIT and is the first incubatee of Clearbridge Accelerator, a high-technology incubator backed by the Singapore Government's National Research Foundation (NRF). For more information, please visit www.biolidics.com.

Clearstatehelpshealthcare clients across different functions and roles, including research and development, strategic planning, marketing and sales, government affairs and new business development, to discover new opportunities and formulate evidence-based strategies.

Credo Diagnostics Biomedical develops, manufactures, and commercializes innovative, cost-effective, and rapid Molecular Diagnostic solutions at the Point-of-Care (POC) in the areas of human infectious diseases and animal health. At Credo Diagnostics Biomedical, we are conscious of the necessity to simplify processes and accelerate molecular testing at lower costs. We believe that effective rapid POC Molecular Diagnostics will redefine healthcare for both human and veterinary clinical management. By providing the right information, at the right time, and to the right people, we can improve the lives of billions of people and animals around the world. For any inquiries, please contact us at: service@credodxbiomed.com

HistoIndex is a digital pathology company based in Singapore, founded in 2010. It specializes in AI-driven, stain-free tissue analysis, focusing on disease assessment, particularly for fibrosis and liver-related conditions. The company utilizes its proprietary Second Harmonic Generation (SHG) imaging technology to provide high-resolution visualization of collagen and other structural proteins, enhancing the accuracy of pathology assessments. HistoIndex offers stain-free digital pathology services that detect and quantify fibrosis, inflammation, and other biomarkers in tissues such as the liver, kidney, and skin. Its AI image-analysis platforms support reproducible quantification of morphological features, which is beneficial for clinical trials and diagnostics. The company collaborates with research institutions and pharmaceutical companies to evaluate drug efficacy in various diseases, including metabolic dysfunction-associated liver conditions. With a global presence, HistoIndex operates imaging centers and maintains partnerships across multiple countries, including the US, UK, and India.

Imagene Labs is a healthcare technology company that provides an enterprise genetics analysis platform for creating personalized products and services based on individuals' DNA insights.

Invitrocue Limited is a biotechnology company based in Singapore, founded in 2012. The company specializes in advanced 3D cell-based models and personalized oncology solutions, operating globally with a presence in Australia, China, Hong Kong, and Germany. Invitrocue offers a range of services, including the Onco Patient-Derived Organoid (PDO) Test, which uses patient-derived tumor cells to tailor cancer treatments. Their 3D CelluSponge Technology provides a scaffold-based system for drug metabolism studies, toxicology assessments, and infectious disease modeling. Additionally, they offer customized services for disease modeling and assays, focusing on respiratory diseases and liver infections, as well as digital pathology and medical imaging to support drug testing and organoid analysis. The company collaborates with industry networks to develop preclinical models, enhancing drug discovery and therapeutic outcomes.

JN Medsys is a people-centered life science company driven by the desire to make complex genomic tools accessible to more people. Through a relentless commitment to innovation, we aim to deliver simplified solutions that achieve improved performance at better affordability. The Clarity digital PCR is the epitome of this vision. It brings digital PCR analysis to the next level by significantly reducing its preparation time and simplifying its workflow. With digital PCR this fast and easy, the choice is now clear. Choose Clarity for your digital PCR needs.

Founded in 2016, MegaRobo is a national high-tech enterprise, headquartered in Beijing, with branches in Shenzhen, Shanghai, and Suzhou; the team size is over 300 persons, with R&D personnel accounting for 60%. Focusing on R&D and the application of robot and intelligent Internet of things, MegaRobo has a number of core technologies that are competitive in the world and has applied for over 200 invention patents, which have passed the IOS9001 Quality Management System Certification. Based in China and facing the world, MegaRobo unremittingly provides industry-leading, efficient, and reliable automation solutions for the life sciences, smart retail, and lightweight manufacturing.

Multidimensional Health Intelligence Platform for digital powered care delivery Mesh Bio is a fast growing digital health startup focused on addressing the growing challenges in care delivery. Mesh Bio develops AI powered clinical decision support, analytics and automation solutions for healthcare providers to transform healthcare delivery with digital solutions. At Mesh Bio, we actively build an environment for personal excellence and career growth. We encourage diversity of experiences/backgrounds and want team members to thrive in their domain of professional expertise.

Micropoint Technologies Pte Ltd was established in 2008 by its founder, Mr. Chee Lim. The company is a spin-off from the Institute of Materials Research & Engineering, wherein he worked for seven years developing the microneedle technology.

NalaGenetics was built with the passion to make preventive, DNA-based precision healthcare accessible to as many people as possible. Specifically, catalyzed by the founders' personal experiences of problematic medication side effects and knowledge of what genetic testing can offer, NalaGenetics aims to help people achieve better nutrition and prescription medication outcomes by analyzing their unique DNA. Today, NalaGenetics' solutions are trusted by a growing number of healthcare providers, laboratories, insurers, and corporates in Asia and Europe. We have also won government grants and mandates to carry out genomic research projects from the Government of Singapore and others. These achievements reflect the company's exceptional standards and depth of research as a scientist-led company, along with a commitment to delivering best-in-class genomic solutions. Find out more about us at www.nalagenetics.com

About NSG BioLabs NSG BioLabs is Singapore's leading and largest co-working BSL-2 laboratory designed specifically to hatch revolutionary biotechnology ventures. With large laboratory benches, several state-of-the-art tissue culture suites, an extensive list of shared core equipment, and a group of very carefully selected tenants and partners in its sites, NSG BioLabs and NSG Ventures is a complete global life sciences incubation ecosystem

We are a molecular life science company dedicated to advancing human health through innovation. By designing and building breakthrough molecular platforms that are both accessible and best-in-class, One BioMed is providing biomedical researchers and clinicians with unprecedented access to cutting-edge tools.

RWDC Industries is on a mission to replace petroleum-derived materials with safe, sustainable alternatives. We have developed technology to harvest outputs of a microbial fermentation process using plant-based oils that produces a naturally occurring biodegradable polymer called PHA (or polyhydroxylalkanoate). PHA's are biopolymers naturally produced by microbial fermentation of plant-based oils or sugar. RWDC's PHA — Solon — is certified by TÜV Austria to be fully biodegradable in soil, water and marine conditions. Solon is 100% biodegradable with no toxic residue. Solon is a global solution to today's plastic waste management challenge, and it's an ideal material for replacing petroleum-derived, single-use plastics — such as cutlery, cups, bags, plates and bowls. Solon safely biodegrades in natural environments, leaving absolutely no harmful remains or byproducts.

SDT Molecular is a Singapore-based company with the vision of bringing advanced technologies and innovative products to healthcare professionals, hospitals and clinical laboratories.

SABio is a biotechnology company that offers quality custom-made RNA oligos/siRNAs, peptides, ready-made antibodies, custom antibody production services, and more.

At TurtleTree, we are pioneering the future of health with our breakthrough product, LF+: the world’s first vegan lactoferrin created through cutting-edge precision fermentation technology. Lactoferrin, a bioactive milk protein, enhances the nutritional profile of a wide range of food and health products. From plant-based alternatives and traditional foods to skincare and cosmetics, LF+ provides exceptional health benefits. Our innovative process not only contributes to human health but also ensures that animals can live carefree, happier lives. As we continue to push the boundaries of food science, we are seeking out partners and investors to join us as we create a healthy and sustainable future. Join the health revolution. Where Nutrition Meets Humanity.